Literature DB >> 14550538

The nuclear protein HMGB1, a new kind of chemokine?

Bernard Degryse1, Maddalena de Virgilio.   

Abstract

The chromosomal protein HMGB1 is now regarded as a proinflammatory cytokine. Importantly, HMGB1 has chemotactic activity suggesting its involvement in the early and late events of the inflammatory reaction. Therefore, HMGB1 has all the hallmarks of a chemokine (chemotactic cytokine). We propose to classify HMGB1 into a new group of proteins unrelated structurally to chemokines but having chemokine-like functions, and to name this class CLF (chemokine-like functions). The CLF class should include other unrelated molecules such as urokinase and its receptor, cytokines macrophage migration inhibitory factor (MIF) and interleukin (IL)-6, anaphylatoxin C5a, ribosomal protein S19, and thioredoxin that have similar chemokine-like activities. This innovative concept may lead to the identification of new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550538     DOI: 10.1016/s0014-5793(03)01027-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

1.  A functional heteromeric MIF receptor formed by CD74 and CXCR4.

Authors:  Verena Schwartz; Hongqi Lue; Sandra Kraemer; Joanna Korbiel; Regina Krohn; Kim Ohl; Richard Bucala; Christian Weber; Jürgen Bernhagen
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

2.  High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.

Authors:  Sharon McClellan; Xiaoyu Jiang; Ronald Barrett; Linda D Hazlett
Journal:  J Immunol       Date:  2015-01-14       Impact factor: 5.422

3.  Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis.

Authors:  Marieke A D van Zoelen; Ahmed Achouiti; Ann-Marie Schmidt; Huan Yang; Sandrine Florquin; Kevin J Tracey; Tom van der Poll
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

4.  CYTL1 Promotes the Activation of Neutrophils in a Sepsis Model.

Authors:  Haiyan Xue; Shu Li; Xiujuan Zhao; Fuzheng Guo; Lilei Jiang; Yaxin Wang; Fengxue Zhu
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

5.  HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression.

Authors:  Yanmei Li; Ping Wang; Jia Zhao; Haonan Li; Dahai Liu; Wei Zhu
Journal:  Mol Cell Biochem       Date:  2017-03-11       Impact factor: 3.396

Review 6.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 7.  Chemokine-like functions of MIF in atherosclerosis.

Authors:  Andreas Schober; Jürgen Bernhagen; Christian Weber
Journal:  J Mol Med (Berl)       Date:  2008-04-02       Impact factor: 4.599

8.  High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues.

Authors:  Jordana Todorova; Evdokia Pasheva
Journal:  Oncol Lett       Date:  2011-10-24       Impact factor: 2.967

9.  The expression of HMGB1 protein and its receptor RAGE in human malignant tumors.

Authors:  Nora Kostova; Stanislava Zlateva; Iva Ugrinova; Evdokia Pasheva
Journal:  Mol Cell Biochem       Date:  2009-10-30       Impact factor: 3.396

10.  Amino acid residues 201-205 in C-terminal acidic tail region plays a crucial role in antibacterial activity of HMGB1.

Authors:  Wei Gong; Yuan Li; Fan Chao; Gang Huang; Fengtian He
Journal:  J Biomed Sci       Date:  2009-09-14       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.